Multiple myeloma analysis from ASH 2017
12 Dec 2017
Multiple myeloma analysis from ASH 2017
Multiple myeloma highlights from ASH 2017
ASH 2017: Immunotherapy for multiple myeloma
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in multiple myeloma
REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies
T cell therapy for ALL
Immunosuppressive therapy in myelodysplastic syndrome
The ACE-LY-004 study of acalabrutinib monotherapy for mantle cell lymphoma
Why we are not ready for personalised medicine
Genetically profiling entire populations, starting with Estonia
Hypomethylating agents for relapsed and refractory acute myeloid leukaemia
How does ancestry affect your health?